GenSight Biologics S.A. (LON:0RIM)
London
· Delayed Price · Currency is GBP · Price in EUR 0.266
-0.024 (-8.43%)
At close: Feb 19, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of 26.37 million as of February 21, 2025. Its market cap has decreased by -0.02% in one year.
Market Cap
26.37M
Enterprise Value
39.38M
Revenue
1.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 212.26M to 26.37M, a decrease of -87.58%. That is a compound annual growth rate of -21.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| Shell | 161.28B |
| HSBC Holdings | 157.51B |
| Unilever | 108.50B |
| Rio Tinto Group | 86.77B |
| RELX PLC | 72.31B |
| BP p.l.c. | 70.06B |
| British American Tobacco p.l.c. | 65.17B |